Funding for this research was provided by:
Bristol-Myers Squibb Foundation
Text and Data Mining valid from 2019-04-11
Received: 21 December 2018
Accepted: 1 April 2019
First Online: 11 April 2019
Ethics approval and consent to participate
: Ethics approval was obtained from the Human Research Ethics Committee of the University of Cape Town (ref: 004/2016), the Research Ethics Committee of the University of the Witwatersrand (ref: M160510) and the Western Cape (ref: WC_2016RP19_818) and KwaZulu-Natal (ref: KZN_2016RP59_986) Provincial Department of Health Ethics Committees. All participants provided written informed consent.
: Not applicable
: AS: is a faculty member of the Bristol-Myers Squibb Foundation and has received an honorarium from Gilead Pharmaceuticals to present hepatitis prevalence data at a South African conference for HIV clinicians.KY: No competing interestsLM: No competing interestsRB: No competing interestsAV: No competing interestsCWS: No competing interestsMS: No competing interestsKR: No completing interestsNPS: No competing interestsJM: No competing interestsAP: No competing interestsHH: No competing interests
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.